Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adenosine A2A receptors modify motor function in MPTP-treated common marmosets

T Kanda1, T Tashiro, Y Kuwana

  • 1Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co Ltd, Shizuoka, Japan.

Neuroreport
|October 6, 1998
PubMed
Summary

Selective adenosine A2A antagonists like KW-6002 increase locomotor activity in Parkinson's disease models. Adenosine A2A receptor agonists reversed this effect, suggesting A2A receptors are a key therapeutic target for Parkinson's disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.

Pharmacology, biochemistry, and behavior·2003
Same author

Inhibition of neuronal nitric oxide synthase increases dopamine efflux from rat striatum.

Journal of neural transmission (Vienna, Austria : 1996)·2003
Same author

Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.

Journal of neural transmission (Vienna, Austria : 1996)·2003
Same author

Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets.

Neuroscience·2002
Same author

Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.

Neuroscience·2002
Same author

The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administration.

Journal of neural transmission (Vienna, Austria : 1996)·2002

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurology

Background:

  • Adenosine receptors A1 and A2 are present in the striatum.
  • These receptors influence locomotor activity.
  • They represent potential therapeutic targets for Parkinson's disease (PD).

Purpose of the Study:

  • To investigate the role of adenosine A1 and A2A receptors in modulating locomotor activity.
  • To evaluate the therapeutic potential of targeting adenosine A2A receptors for PD treatment.

Main Methods:

  • Administration of selective adenosine A2A antagonist KW-6002 to MPTP-treated common marmosets.
  • Administration of selective A1 receptor antagonist DPCPX.
  • Administration of adenosine A2A receptor agonist APEC.
  • Assessment of locomotor activity changes.

Related Experiment Videos

Main Results:

  • KW-6002 significantly increased locomotor activity.
  • DPCPX had no effect on locomotion.
  • APEC dose-dependently suppressed basal locomotor activity.
  • APEC reversed the KW-6002-induced increase in locomotion.

Conclusions:

  • Adenosine A2A receptors play a critical role in regulating locomotor activity.
  • Selective adenosine A2A antagonism shows potential for treating PD symptoms.
  • Adenosine A2A receptors are a promising therapeutic target for basal ganglia disorders, including PD.